about
Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activityEvaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolismLeukocystatin, a new Class II cystatin expressed selectively by hematopoietic cellsInhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationshipBiochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideCrystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug designStructure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparumReverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissueTargeting the active site of the placental isozyme of alkaline phosphatase by phage-displayed scFv antibodies selected by a specific uncompetitive inhibitorPreclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)Preclinical Characterization of PF-00868554, a Potent Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA PolymeraseInhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibodyMechanism of inactivation of ornithine transcarbamoylase by Ndelta -(N'-Sulfodiaminophosphinyl)-L-ornithine, a true transition state analogue? Crystal structure and implications for catalytic mechanismStructure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand bindingNinety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap RegionStructure of an Fab–Protease Complex Reveals a Highly Specific Non-canonical Mechanism of InhibitionEnzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavirMolecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor DarunavirDevelopment and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductaseMolecular Characterization of a Class I P450 Electron Transfer System from Novosphingobium aromaticivorans DSM12444The structure of a Burkholderia pseudomallei immunophilin–inhibitor complex reveals new approaches to antimicrobial developmentHLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanismUnique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vectorA Reverse Binding Motif That Contributes to Specific Protease Inhibition by AntibodiesStructure and function of CYP108D1 from Novosphingobium aromaticivorans DSM12444: an aromatic hydrocarbon-binding P450 enzymeMutations in HIV-1 gag and pol Compensate for the Loss of Viral Fitness Caused by a Highly Mutated ProteaseA Structural Biology Approach Enables the Development of Antimicrobials Targeting Bacterial ImmunophilinsThe crystal structures of 4-methoxybenzoate bound CYP199A2 and CYP199A4: structural changes on substrate binding and the identification of an anion binding siteImproving the affinity and activity of CYP101D2 for hydrophobic substratesInvestigation of the substrate range of CYP199A4: modification of the partition between hydroxylation and desaturation activities by substrate and protein engineeringEnzyme-substrate complex structures of CYP154C5 shed light on its mode of highly selective steroid hydroxylationNovel Furin Inhibitors with Potent Anti-infectious ActivityCatalytic activity of human ADAM33Beta-lactamase inhibitors. The inhibition of serine beta-lactamases by specific boronic acidsThe inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxinL-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitorIn vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatineChemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptaseAntitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domainCharacterization of anti-hemostatic factors in the argasid, Argas monolakensis: implications for the evolution of blood-feeding in the soft tick family
P2860
Q22008720-FDC0F123-E7FA-4524-BF95-396978B7A2BFQ24300310-C222D579-A1BF-4B71-9F88-7A8F476508D9Q24308558-3A429B1C-6DE8-452A-822A-F7C9C7E87804Q24527865-28EFD318-4CE3-4A05-96DF-58044BFFFD3DQ24535668-E5A3C89E-B5EF-4EAB-90B1-0B9E445E2404Q24562097-CE600FA7-A422-480D-B61D-00BDDB096BE9Q24597864-C83715BC-2EC2-497B-A727-975D62CE5A34Q24614528-AFC79DE3-FD36-4C58-A10E-DCC29245484FQ25255701-5D0ADCB0-8AAB-4DF2-ABC6-583A504974C5Q27487391-A01626DF-32E7-49E6-ADF0-2A5DB2867121Q27488428-8E7A21C2-0142-4C36-846D-F73A06F4C5EFQ27620967-24D7BCA6-8075-4606-A460-CFBA2F7C1128Q27622067-C029D709-1C13-4CEF-AADB-8012223B76EAQ27649106-002654A2-0AE0-4E9C-93F6-014D16834D2CQ27650299-CDD7B0EC-13CD-475E-B68D-496FCE257CE3Q27650727-84D9386A-2846-4F73-89A7-76A73800B945Q27650863-D72B1CA6-A5CC-46FF-AB58-CA8B010D8759Q27656031-85B44278-3CAA-4769-9C35-F5A4189D4B3CQ27657419-739B5D4F-C9EF-4149-8523-CD6BE7C9ADF2Q27662700-D7C95B94-CC53-4451-81BD-ECBA0B741CCFQ27667867-C5A3FFCD-EF1F-4C79-AE5A-407F5E35831CQ27675409-A913CB06-DF8D-42AC-AD02-2BD6EEFB2AEFQ27675420-8F0B14E0-F63B-4396-9484-6F197463F6B3Q27676066-F1458193-67B6-4C0B-B285-A325F50F3765Q27677375-CDB4DFD8-6753-4BC0-B776-6D8025874B6CQ27679341-48C2054F-6E13-499C-BB70-DA18869D7092Q27681063-55A008E1-1389-498A-80F1-7C3F392E32E2Q27681160-1902EB7A-0A51-4D4D-932D-5F8CE83FBC3DQ27681804-F1AF1F09-6F11-4839-B7CB-F07E6187CA7FQ27683280-F8731B34-B69C-411C-9C9B-E29806896D9AQ27696143-0522995C-592F-4242-8728-637453F12ED1Q27700845-BE5EF125-7DCA-49FC-8943-B712441DC680Q28191609-210A877C-AF97-4A32-8A96-783FE2962303Q28361027-61E82CEB-8FB8-48EC-8F99-C7A552B13AF2Q28366507-176889FC-56BC-458A-8350-CCD15952BF16Q28369664-CA917ACC-DB3E-40DA-859B-6BCD15025639Q28378709-039B564A-5C22-479F-8A17-108192D582E7Q28379510-BB589129-8B80-44FE-A2A8-291D0BD57F51Q28487064-7B16E9DA-40B2-40A9-9987-237A0CBFBBACQ28649401-353A850A-1132-41E6-B188-4FE9DF899ED3
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh-hant
name
The kinetics of reversible tight-binding inhibition.
@en
The kinetics of reversible tight-binding inhibition.
@nl
type
label
The kinetics of reversible tight-binding inhibition.
@en
The kinetics of reversible tight-binding inhibition.
@nl
prefLabel
The kinetics of reversible tight-binding inhibition.
@en
The kinetics of reversible tight-binding inhibition.
@nl
P1476
The kinetics of reversible tight-binding inhibition.
@en
P2093
Morrison JF
Williams JW
P304
P356
10.1016/0076-6879(79)63019-7
P407
P577
1979-01-01T00:00:00Z